Search company, investor...
Caladrius Biosciences company logo

Caladrius Biosciences

Founded Year



Acq - Pending | Acquired

Total Raised


About Caladrius Biosciences

Caladrius Biosciences is a clinical-stage development company with cell therapy products in development based on multiple technology platforms and targeting autoimmune and select cardiology indications. The company was founded in 2006 and is based in Basking Ridge, New Jersey.

Headquarters Location

110 Allen Road 2nd Floor

Basking Ridge, New Jersey, 07920,

United States


Missing: Caladrius Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Caladrius Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Caladrius Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Caladrius Biosciences is included in 2 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Medical Devices

8,605 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Caladrius Biosciences Patents

Caladrius Biosciences has filed 12 patents.

patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Immunology, Immune system, Transcription factors, Cancer vaccines


Application Date


Grant Date



Related Topics

Clusters of differentiation, Immunology, Immune system, Transcription factors, Cancer vaccines



Latest Caladrius Biosciences News

Global Diabetes Stem Cell Therapy Market SWOT Analysis and Growth Strategies 2023-2033

Nov 18, 2022

Global Diabetes Stem Cell Therapy Market SWOT Analysis and Growth Strategies 2023-2033 Pune, Maharashtra, November 18 2022 (Wiredrelease) Market.Biz –:Global Key Players In the Diabetes Stem Cell Therapy Market Include ViaCyte; Sernova; Semma Therapeutics (Vertex); Caladrius Biosciences; Novo Nordisk; Throne Biotechnologies Inc; Athersys, etc. Market.Biz has recently published a research report on Global Diabetes Stem Cell Therapy Market Growth Trends and Competitive Analysis, It will provide a comprehensive overview of the Diabetes Stem Cell Therapy Market Dynamics. They have provided deep insights into key factors that influence growth. The industry forecasts and estimates were also accurately and reliably provided by the researchers. The report’s buyers will have access to the global Diabetes Stem Cell Therapy data based on volume and value. The report will help readers understand the dynamics of the future and its impact on it. Interested in this report? Fill Out Details To Receive Sample Report PDF: Market Key Trends for Diabetes Stem Cell Therapy: This section will give readers a clear understanding of the past, upcoming and recent trends. This section will assist players in identifying these opportunities and maximizing them to strengthen their position over the coming years. They will be able to identify risks and solve tough problems in the new landscape. Covid Impact Study: This study will help you understand the effects of the Covid-19 pandemic. The research report covers aspects such as supply chain management, demand, production, export, and import. Market.Biz has also examined the factors that will help the Diabetes Stem Cell Therapy industry to gain momentum and facilitate growth over the next years. Market Segmental Study for Diabetes Stem Cell Therapy: This research report was analyzed by type and application segments. This section examines the growth opportunities each segment will have in the coming years. The analysts have performed a Diabetes Stem Cell Therapy sales analysis for each type of segment, and have provided reliable data regarding revenue and volume for 2016-2030. The report also includes a sales forecast and analysis of each type of segment and application segment, based on the volume of 2016-2030. Segment by Type: Type 1 Diabetes Type 2 Diabetes Buy This Premium Research Report (Single User Licence: US$ 3300 Or Multi User Licence: US$ 4890 Or Corporate User: US$ 6500): Regional Study: This report examines the key regions of North America; Europe; Asia Pacific; Latin America; The Middle East & Africa. This section has highlighted key factors that play a role in regional growth. Our team of experts and analysts has provided forecasts and estimates at the country and regional levels. This section discusses the Diabetes Stem Cell Therapy regional and country sales growth for the period 2016-2022. The researchers have done reliable volume analysis by region and sales volume analysis by country for the period 2016-2030. To give the reader a clear understanding, the Diabetes Stem Cell Therapy report includes production capacity statistics. Market Competition: The report authors have a detailed analysis of each major player in the Diabetes Stem Cell Therapy market. The report includes detailed data on the value, sales, ex-factory price, revenue, and share of manufacturers over the period 2016-2030. A detailed revenue and price analysis for all Diabetes Stem Cell Therapy manufacturers worldwide will be available to the readers in the period 2016-2022. Clients will be able to see the current status of the global Diabetes Stem Cell Therapy market, as well as the future potential competition. We can provide the revenue and sales figures for companies that you are interested in, from 2016 to 2022. The diabetes Stem Cell Therapy Research Report Includes The Following Key Players: ViaCyte Sernova Semma Therapeutics (Vertex) Caladrius Biosciences Novo Nordisk Throne Biotechnologies Inc Athersys Key Growth Strategies: This section examines the growth strategies of the Diabetes Stem Cell Therapy players to maintain their position, including collaborations, intensification, and diversification of product portfolios and geographic expansion. This section provides information on the most recent product innovations, mergers, and acquisitions. Most Frequently Asked Questions: What are the main challenges facing Diabetes Stem Cell Therapy market players? What are the top players in the Diabetes Stem Cell Therapy Market? Which regions will experience slow growth? What growth strategies are employed by Diabetes Stem Cell Therapy market players What application segment will be dominant in the future market? Which regions will offer growth opportunities in the Diabetes Stem Cell Therapy market What will the global Diabetes Stem Cell Therapy market revenues be by 2030? What are the most recent product innovations in Diabetes Stem Cell Therapy? Which product segment is likely to see the greatest growth? Any Query? Enquire Here For Discount Or Report Customization: Why Purchase Diabetes Stem Cell Therapy Market Report? This report provides a comprehensive overview of the Global Diabetes Stem Cell Therapy Industry Research Report and Growth Trends and Competitive Analysis 2023-2030. It contains the most valuable and actionable insights derived from an extensive analysis of the Diabetes Stem Cell Therapy industry. This helps to identify profitable trends and make the right decisions. The report provides benchmarking industry leaders and their pricing strategies. This report helps to identify profitable industry trends worth investing in. It also helps to identify both the short- and long-term opportunities and threats to businesses. This report is a solid, reliable source of information that will eventually lead to better and faster business decisions. Contact Us: Phone No: +1(857)4450045, +91 9130855334. Centrifugal Compressor Market Competitors Analysis: Atlas Copco, EBARA, Ingersoll Rand, Cooper (EATON): Trampoline Park Equipment Market Top Insights: Multiplay UK, JumpSport, Fun Spot, Pure Fun: Clostridium Vaccine (Animal Health) Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: Constipation Treatment Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: Cryptococcosis Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: Diabetic Foot Ulcers and Pressure Ulcers Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: Dry Eye Disease Market Business Growth, Industry Research, Top Key Players Survey- Market.Biz: This content has been published by Market.Biz company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at . Editor Details

Caladrius Biosciences Frequently Asked Questions (FAQ)

  • When was Caladrius Biosciences founded?

    Caladrius Biosciences was founded in 2006.

  • Where is Caladrius Biosciences's headquarters?

    Caladrius Biosciences's headquarters is located at 110 Allen Road, Basking Ridge.

  • What is Caladrius Biosciences's latest funding round?

    Caladrius Biosciences's latest funding round is Acq - Pending.

  • How much did Caladrius Biosciences raise?

    Caladrius Biosciences raised a total of $2.88M.

  • Who are the investors of Caladrius Biosciences?

    Investors of Caladrius Biosciences include Lisata Therapeutics, U.S. Department of Defense, RimAsia Capital Partners, Enhance Biomedical Holding Corporation, Iroquois Capital Group and 4 more.

  • Who are Caladrius Biosciences's competitors?

    Competitors of Caladrius Biosciences include Quell Therapeutics, Healthgrades, ExamWorks, InstaMed, Clario Medical Imaging and 12 more.

Compare Caladrius Biosciences to Competitors

AssureImmune Logo

AssureImmune - a science based cell preservation leader - aims to provide its clients with private adult stem cell collection and preservation medical services worldwide. The company specializes in collecting, testing, and banking an individual's own healthy adult stem cells from the peripheral blood of adults and from the cord blood of healthy new born infants.


Neurobank takes neural stem cells in spinal fluid and extracts the cells and prepares and keeps them. Per the company, they own four patents on their process.

Stellacure Logo

Stellacure is a public-private umbilical stem cell storage bank. Stellacure works in close cooperation with the German Red Cross.

HEARx West

HEARx West offers hearing aid centers

Achieve CCA Logo
Achieve CCA

Achieve CCA is a provider of debt management services to healthcare patients.

AssistGuide Information Services Network

AssistGuide Information Services (AGIS) Network connects government agencies, employers, health care providers and consumers so people can be informed and gain access to elder care and long term care support services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.